{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T23:22:30Z","timestamp":1768346550122,"version":"3.49.0"},"reference-count":39,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2021,11,23]],"date-time":"2021-11-23T00:00:00Z","timestamp":1637625600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2020R1F1A1074898"],"award-info":[{"award-number":["NRF-2020R1F1A1074898"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Purpose<\/jats:title>\n<jats:p>To evaluate changes in choroidal vascular structure and aqueous cytokine levels in eyes with vitreoretinal lymphoma (VRL) after intravitreal methotrexate (MTX) treatment.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods<\/jats:title>\n<jats:p>In this retrospective study, VRL patients who visited our hospital between October 2018 and July 2020 were reviewed. Aqueous samples were obtained before treatment and at clinical resolution after intravitreal MTX therapy. Interleukin (IL)-6 and IL-10 levels and the IL-10-to-IL-6 ratio were evaluated. Swept-source optical coherence tomographic images were obtained along with the aqueous samples. Subfoveal choroidal thickness (SFCT), total vascular area of the choroid (TCA), stromal area (SA), luminal area (LA), and choroidal vascularity index (CVI) were assessed.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Results<\/jats:title>\n<jats:p>Twelve patients were enrolled (female:male\u20145:7). The mean age (\u00b1 standard deviation) at diagnosis was 60.9\u00b18.5 years. In the 16 eyes diagnosed with VRL, values of SFCT, TCA, LA, and SA significantly decreased after treatment (all p-values &lt;0.05). Additionally, the aqueous cytokine IL-10 level and IL-10-to-IL-6 ratio were significantly decreased (p = 0.001 and p = 0.003, respectively). The choroidal structure in the non-treated fellow eyes did not show any significant difference. There were no further changes in SFCT, TCA, LA, or CVI that occurred during maintenance therapy. For clinical remission, the patients received 7.7\u00b15.5 intravitreal MTX injections. The required number of injections for clinical remission was positively correlated with best-corrected visual acuity, IL-10, and IL-6 levels in the active phase (p = 0.035, p = 0.009, and p = 0.031, respectively).<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusion<\/jats:title>\n<jats:p>Eyes with active VRL exhibited choroidal thickening with increased vascular and stromal areas that decreased after remission following MTX treatment. Higher aqueous IL-10 and IL-6 levels and lower visual acuity in the active phase may indicate the number of injections required for remission; this should be considered in the treatment of patients with VRL.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0260469","type":"journal-article","created":{"date-parts":[[2021,11,23]],"date-time":"2021-11-23T20:09:27Z","timestamp":1637698167000},"page":"e0260469","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":4,"title":["Changes in choroidal vascular structure from vitreoretinal lymphoma and the intraocular cytokine level associated with clinical resolution after intravitreal methotrexate treatment"],"prefix":"10.1371","volume":"16","author":[{"given":"Rae-Young","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae Hyun","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirinae","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young-Geun","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5429-4839","authenticated-orcid":true,"given":"Seok-Goo","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9978-6215","authenticated-orcid":true,"given":"Young-Hoon","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2021,11,23]]},"reference":[{"issue":"11","key":"pone.0260469.ref001","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1634\/theoncologist.2011-0210","article-title":"Primary vitreoretinal lymphoma: a report from an International Primary Central Nervous System Lymphoma Collaborative Group symposium","volume":"16","author":"CC Chan","year":"2011","journal-title":"Oncologist"},{"issue":"5","key":"pone.0260469.ref002","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.survophthal.2013.12.001","article-title":"Primary intraocular lymphoma","volume":"59","author":"MS Sagoo","year":"2014","journal-title":"Surv Ophthalmol"},{"issue":"20","key":"pone.0260469.ref003","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"SH Swerdlow","year":"2016","journal-title":"Blood"},{"issue":"4","key":"pone.0260469.ref004","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1076\/ocii.8.4.243.6463","article-title":"Ocular and central nervous system lymphoma: clinical features and diagnosis","volume":"8","author":"N Cassoux","year":"2000","journal-title":"Ocul Immunol Inflamm"},{"issue":"12","key":"pone.0260469.ref005","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1016\/S0161-6420(87)33256-7","article-title":"Clinical features, laboratory investigations, and survival in ocular reticulum cell sarcoma","volume":"94","author":"LN Freeman","year":"1987","journal-title":"Ophthalmology"},{"issue":"10","key":"pone.0260469.ref006","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1001\/jamaophthalmol.2017.3286","article-title":"Association of Disease Location and Treatment With Survival in Diffuse Large B-Cell Lymphoma of the Eye and Ocular Adnexal Region","volume":"135","author":"AH Ahmed","year":"2017","journal-title":"JAMA Ophthalmol"},{"issue":"6","key":"pone.0260469.ref007","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/j.1442-9071.2008.01843.x","article-title":"Understanding intraocular lymphomas","volume":"36","author":"SE Coupland","year":"2008","journal-title":"Clinical & Experimental Ophthalmology"},{"issue":"4","key":"pone.0260469.ref008","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1046\/j.1365-2141.2003.04800.x","article-title":"Biological diagnosis of primary intraocular lymphoma","volume":"124","author":"H Merle-B\u00e9ral","year":"2004","journal-title":"Br J Haematol"},{"issue":"3","key":"pone.0260469.ref009","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1080\/09273940802702553","article-title":"Cytokine and molecular analyses of intraocular lymphoma","volume":"17","author":"K Ohta","year":"2009","journal-title":"Ocular immunology and inflammation"},{"issue":"7","key":"pone.0260469.ref010","doi-asserted-by":"crossref","first-page":"3253","DOI":"10.1167\/iovs.06-0031","article-title":"IL-10 measurement in aqueous humor for screening patients with suspicion of primary intraocular lymphoma","volume":"48","author":"N Cassoux","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"pone.0260469.ref011","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1097\/IAE.0000000000001922","article-title":"USE OF A THRESHOLD OF INTERLEUKIN-10 AND IL-10\/IL-6 RATIO IN OCULAR SAMPLES FOR THE SCREENING OF VITREORETINAL LYMPHOMA","volume":"38","author":"C Pochat-Cotilloux","year":"2018","journal-title":"Retina"},{"issue":"1","key":"pone.0260469.ref012","doi-asserted-by":"crossref","first-page":"15992","DOI":"10.1038\/s41598-020-73111-2","article-title":"Serial changes in the aqueous IL-10 level after intravitreal methotrexate injection as an indicator of primary vitreoretinal lymphoma recurrence","volume":"10","author":"YG Park","year":"2020","journal-title":"Sci Rep"},{"issue":"3","key":"pone.0260469.ref013","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1159\/000447412","article-title":"Multimodal Imaging of Vitreoretinal Lymphoma","volume":"236","author":"C Mapelli","year":"2016","journal-title":"Ophthalmologica"},{"issue":"4","key":"pone.0260469.ref014","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/ICB.0000000000000053","article-title":"Sequential multimodal imaging findings in a case of primary vitreoretinal lymphoma","volume":"8","author":"R Dolz-Marco","year":"2014","journal-title":"Retin Cases Brief Rep"},{"issue":"3","key":"pone.0260469.ref015","first-page":"268","article-title":"Spectral-domain Optical Coherence Tomography Patterns in Intraocular Lymphoma","volume":"24","author":"H Keino","year":"2016","journal-title":"Ocul Immunol Inflamm"},{"issue":"10","key":"pone.0260469.ref016","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1136\/bjophthalmol-2017-311612","article-title":"Characteristic optical coherence tomography findings in patients with primary vitreoretinal lymphoma: a novel aid to early diagnosis","volume":"102","author":"RJ Barry","year":"2018","journal-title":"Br J Ophthalmol"},{"key":"pone.0260469.ref017","doi-asserted-by":"crossref","first-page":"100797","DOI":"10.1016\/j.preteyeres.2019.100797","article-title":"Optical coherence tomography diagnostic signs in posterior uveitis","volume":"75","author":"F Pichi","year":"2020","journal-title":"Prog Retin Eye Res"},{"issue":"12","key":"pone.0260469.ref018","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1007\/s00417-016-3395-x","article-title":"Optical coherence tomography manifestations of primary vitreoretinal lymphoma","volume":"254","author":"T Saito","year":"2016","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"4","key":"pone.0260469.ref019","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1080\/09273948.2019.1616769","article-title":"Retinal and Choroidal Changes of Vitreoretinal Lymphoma from Active to Remission Phase after Intravitreal Rituximab","volume":"28","author":"MV Cicinelli","year":"2020","journal-title":"Ocul Immunol Inflamm"},{"issue":"6","key":"pone.0260469.ref020","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/aos.14036","article-title":"Combined cellular and soluble mediator analysis for improved diagnosis of vitreoretinal lymphoma","volume":"97","author":"J de Hoog","year":"2019","journal-title":"Acta Ophthalmol"},{"issue":"6","key":"pone.0260469.ref021","doi-asserted-by":"crossref","first-page":"e668","DOI":"10.1111\/aos.14347","article-title":"The importance of cytokines analysis in the diagnosis of vitreoretinal lymphoma","volume":"98","author":"S Frenkel","year":"2020","journal-title":"Acta Ophthalmol"},{"issue":"7","key":"pone.0260469.ref022","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.ophtha.2020.01.042","article-title":"Logistic Regression Classification of Primary Vitreoretinal Lymphoma versus Uveitis by Interleukin 6 and Interleukin 10 Levels","volume":"127","author":"DE Kuo","year":"2020","journal-title":"Ophthalmology"},{"issue":"22","key":"pone.0260469.ref023","doi-asserted-by":"crossref","first-page":"5034","DOI":"10.1200\/JCO.2005.13.524","article-title":"Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma","volume":"23","author":"LE Abrey","year":"2005","journal-title":"J Clin Oncol"},{"key":"pone.0260469.ref024","doi-asserted-by":"crossref","first-page":"21090","DOI":"10.1038\/srep21090","article-title":"Choroidal vascularity index as a measure of vascular status of the choroid: Measurements in healthy eyes from a population-based study","volume":"6","author":"R Agrawal","year":"2016","journal-title":"Sci Rep"},{"key":"pone.0260469.ref025","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s12886-015-0127-7","article-title":"Changes of choroidal structure after treatment for primary intraocular lymphoma: retrospective, observational case series","volume":"15","author":"M Egawa","year":"2015","journal-title":"BMC Ophthalmol"},{"issue":"8","key":"pone.0260469.ref026","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1080\/09273948.2018.1530364","article-title":"Choroidal Vascularity Index and Choroidal Thickness in Human Leukocyte Antigen-B27-Associated Uveitis","volume":"27","author":"M Kim","year":"2019","journal-title":"Ocul Immunol Inflamm"},{"issue":"3","key":"pone.0260469.ref027","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0161-6420(99)00087-1","article-title":"Comparison between optical coherence tomography and fundus fluorescein angiography for the detection of cystoid macular edema in patients with uveitis","volume":"107","author":"RJ Antcliff","year":"2000","journal-title":"Ophthalmology"},{"issue":"6","key":"pone.0260469.ref028","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.ajo.2015.02.009","article-title":"Quantitative analysis of peripheral vasculitis, ischemia, and vascular leakage in uveitis using ultra-widefield fluorescein angiography","volume":"159","author":"M Karampelas","year":"2015","journal-title":"Am J Ophthalmol"},{"issue":"9","key":"pone.0260469.ref029","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1001\/archopht.1978.03910060294024","article-title":"The structural basis of altered vascular permeability following intraocular inflammation","volume":"96","author":"EL Howes","year":"1978","journal-title":"Arch Ophthalmol"},{"issue":"4","key":"pone.0260469.ref030","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1167\/tvst.5.4.7","article-title":"Choroidal Vascularity Index in Vogt-Koyanagi-Harada Disease: An EDI-OCT Derived Tool for Monitoring Disease Progression","volume":"5","author":"R Agrawal","year":"2016","journal-title":"Transl Vis Sci Technol"},{"key":"pone.0260469.ref031","first-page":"1","article-title":"Choroidal Vascular Changes in Multiple Evanescent White Dot Syndrome","author":"M Pellegrini","year":"2019","journal-title":"Ocul Immunol Inflamm"},{"issue":"1","key":"pone.0260469.ref032","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.ophtha.2013.06.046","article-title":"Choroidal lymphoma: clinical features and association with systemic lymphoma","volume":"121","author":"A Mashayekhi","year":"2014","journal-title":"Ophthalmology"},{"issue":"2","key":"pone.0260469.ref033","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1167\/iovs.04-0869","article-title":"Murine model of primary intraocular lymphoma","volume":"46","author":"CC Chan","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"pone.0260469.ref034","doi-asserted-by":"crossref","first-page":"15715","DOI":"10.1038\/s41598-020-72962-z","article-title":"Vitreous levels of interleukin-35 as a prognostic factor in B-cell vitreoretinal lymphoma","volume":"10","author":"A Takeda","year":"2020","journal-title":"Sci Rep"},{"issue":"6","key":"pone.0260469.ref035","doi-asserted-by":"crossref","first-page":"e65627","DOI":"10.1371\/journal.pone.0065627","article-title":"Effect of intravitreal methotrexate and rituximab on interleukin-10 levels in aqueous humor of treated eyes with vitreoretinal lymphoma","volume":"8","author":"H Raja","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"pone.0260469.ref036","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1167\/iovs.11-8782","article-title":"Diurnal variation of choroidal thickness in normal, healthy subjects measured by spectral domain optical coherence tomography","volume":"53","author":"CS Tan","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"pone.0260469.ref037","doi-asserted-by":"crossref","first-page":"5121","DOI":"10.1167\/iovs.11-7364","article-title":"Diurnal variations in axial length, choroidal thickness, intraocular pressure, and ocular biometrics","volume":"52","author":"R Chakraborty","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"pone.0260469.ref038","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ophtha.2012.07.048","article-title":"Subfoveal choroidal thickness: the Beijing Eye Study","volume":"120","author":"WB Wei","year":"2013","journal-title":"Ophthalmology"},{"issue":"7","key":"pone.0260469.ref039","doi-asserted-by":"crossref","first-page":"e612","DOI":"10.1111\/aos.13044","article-title":"Choroidal vascularity index\u2014a novel optical coherence tomography parameter for disease monitoring in diabetes mellitus?","volume":"94","author":"KA Tan","year":"2016","journal-title":"Acta Ophthalmol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0260469","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,23]],"date-time":"2021-11-23T20:10:07Z","timestamp":1637698207000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0260469"}},"subtitle":[],"editor":[{"given":"Demetrios G.","family":"Vavvas","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2021,11,23]]},"references-count":39,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2021,11,23]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0260469","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,23]]}}}